Description: Rua Life Sciences Plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in the United Kingdom. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as Reaction Injection Molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to Rua Life Sciences Plc in June 2020. Rua Life Sciences Plc was incorporated in 1996 and is based in Glasgow, the United Kingdom.
Home Page: rualifesciences.com
RUA Technical Analysis
2 Drummond Crescent
Ayrshire,
KA11 5AN
United Kingdom
Phone:
44 12 9431 7073
Officers
| Name | Title |
|---|---|
| Mr. William Donald Brown | Exec. Chairman |
| Mr. John McKenna | Director of Clinical Marketing & Exec. Director |
| Dr. Caroline Stretton | Group MD & Director |
| Mr. Lachlan Smith | CFO & Director |
| Mr. Iain Anthony | Director of Clinical & Regulatory Affairs and Director |
| K. M. Full FCCA | Company Sec. |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.1119 |
| Price-to-Sales TTM: | 4.5052 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 38 |